Search This Blog

Thursday, May 9, 2019

Mersana Therapeutics reports Q1 EPS 72c, consensus (2c)

Reports Q1 revenue $41.0M, consensus $20.6M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)